Changes in fat contents of US snack foods in response to mandatory trans fat labelling

Public Health Nutrition

Volumn 15, Issue 6, 2012, Pages 1130-1137

  Van Camp, Debra ^a   Hooker, Neal H ^b   Lin, Chung Tung Jordan ^c  

^a Nielsen   (United States)

^b SAINT JOSEPH S UNIVERSITY   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Fat; Nutrition labels; Product reformulation

Indexed keywords

FATTY ACID; TRANS FATTY ACID;

ANALYSIS OF VARIANCE; ARTICLE; FAST FOOD; FAT INTAKE; FOOD ANALYSIS; FOOD PACKAGING; GOVERNMENT REGULATION; HUMAN; LEGAL ASPECT; UNITED STATES;

ANALYSIS OF VARIANCE; DIETARY FATS; FATTY ACIDS; FOOD ANALYSIS; FOOD LABELING; GOVERNMENT REGULATION; HUMANS; SNACKS; TRANS FATTY ACIDS; UNITED STATES;

MLCS; MLOWN;

EID: 84864132872     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S1368980012000079     Document Type: Article

References (27)

1. Lopez-Garcia E (2005) Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 135, 562-566. (Pubitemid 40365218)
2. Mensink RP, Zock PL, Kester A et al. (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol ratio and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77, 1146-1155. (Pubitemid 44858429)
3. Clifton P, Keogh J & Noakes M (2004) Trans fatty acids in adipose tissue and the food supply are associated with myocardial infarction. J Nutr 134, 874-879. (Pubitemid 38456257)
4. Mozaffarian D, Katan M, Ascerio A et al. (2006) Medical progress - trans fatty acids and cardiovascular disease. N Engl J Med 354, 1601-1613.
5. Micha R & Mozaffarian D (2008) Trans fatty acids: effects on cardiometabolic health and implications for policy. Prostaglandins Leukot Essent Fatty Acids 79, Suppl. 1, 147-152.
6. Food and Nutrition Board, Institute of Medicine (2005) Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: The National Academies Press.
7. Allison DB, Egan S, Barraj LM et al. (1999) Estimated intakes of trans fatty and other fatty acids in the US population. J Am Diet Assoc 99, 166-174. (Pubitemid 29077342)
8. Unnevehr LJ & Jagmanaite E (2008) Getting rid of trans fats in the US diet: policies, incentives and progress. Food Policy 33, 497-503.
9. Food and Drug Administration (2003) Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and Health Claims. Final Rule. Federal Register 68, 41434-41506.
10. Moss J (2006) Labeling of trans fatty acid content in food, regulations and limits - the FDA view. Atheroscler Suppl 7, 57-59. (Pubitemid 43831753)
11. Mozaffarian D, Jacobson MF & Greenstein JS (2010) Food reformulations to reduce trans fatty acids. N Engl J Med 362, 2037-2039.
12. Ratnayake WMN, L'Abbe MR & Mozaffarian D (2009) Nationwide product reformulations to reduce trans fatty acids in Canada: when trans goes out, what goes in? Eur J Clin Nutr 63, 808-811.
13. Tarrago-Trani MT, Phillips KM & Lemar LE (2006) New and existing oils and fats used in products with reduced transfatty acid content. J Am Diet Assoc 106, 867-880. (Pubitemid 43729432)
14. Eckel RH, Borra S, Lichtenstein AH et al. (2007) Understanding the complexity of trans fatty acid reduction in the American diet: American Heart Association Trans Fat Conference 2006: report of the Trans Fat Conference Planning Group. Circulation 115, 2231-2246. (Pubitemid 46659080)
15. Satchithanandam S, Oles CJ, Spease CJ et al. (2004) Trans, saturated, and unsaturated fat in foods in the United States prior to mandatory trans-fat labeling. Lipids 39, 11-18. (Pubitemid 38296121)
16. Mintel International Group Ltd (2011) GNPD [Global New Products Database]. How we do it. http://www.gnpd.com/sinatra/gnpd&lang5br/info/ id5how (accessed February 2011).
17. Food and Drug Administration (2009) Reference Amount Customarily Consumer per Eating Occasion. 21 CFR 101.12. http://www.accessdata.fda.gov/scripts/cdrh/ cfdocs/cfcfr/CFRSearch.cfm?fr5101.12 (accessed August 2011).
18. Mozaffarian D & Clarke R (2009) Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr 63, Suppl. 2, S22-S33.
19. O'Brien A & Richard D (2009) Fats and Oils: Formulating and Processing for Applications, 3rd ed. Boca Raton, FL: Taylor & Francis.
20. Hunter JE, Zhang J & Kris-Etherton KM (2010) Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr 91, 46-63.
21. Singh D, Rezac ME & Pfromm PH (2009) Partial hydrogenation of soybean oil with minimal trans fat production using a Pt-decorated polymeric membrane reactor. J Am Oil Chem Soc 86, 93-101.
22. Dijkstra A (2006) Revisiting the formation of trans isomers during partial hydrogenation of triacylglycerol oils. Eur J Lipid Sci Technol 108, 249-264.
23. Skeaff CM (2009) Feasibility of recommending certain replacement or alternative fats. Eur J Clin Nutr 63, Suppl. 2, S34-S49.
24. Wansink B & Chandon P (2006) Can 'low-fat' nutrition labels lead to obesity? J Mark Res 43, 605-617. (Pubitemid 44845878)
25. Howlett E, Burton S & Kozup J (2008) How modification of the Nutrition Facts panel influences consumers at risk for heart disease: the case of trans fat. J Public Policy Mark 27, 83-97.
26. Kozup J, Burton S & Creyer E (2006) The provision of trans fat information and its interaction with consumer knowledge. J Consum Aff 40, 163-176. (Pubitemid 43642703)
27. Lin CTJ & Yen ST (2010) Knowledge of dietary fats among United States consumers. J Am Diet Assoc 110, 613-618.